nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A mixture model to assess the the immunogenicity of an oral rotavirus vaccine among healthy infants in Niger
|
Hitchings, Matt D.T. |
|
|
38 |
51 |
p. 8161-8166 |
artikel |
2 |
A novel gonorrhea vaccine composed of MetQ lipoprotein formulated with CpG shortens experimental murine infection
|
Sikora, Aleksandra E. |
|
|
38 |
51 |
p. 8175-8184 |
artikel |
3 |
Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations
|
Rosenthal, Elizabeth M. |
|
|
38 |
51 |
p. 8206-8215 |
artikel |
4 |
Assignment of opsonic values to pneumococcal reference serum 007sp and a second pneumococcal OPA calibration serum panel (Ewha QC sera panel B) for 11 serotypes
|
Burton, Robert L. |
|
|
38 |
51 |
p. 8145-8153 |
artikel |
5 |
Association of Bacillus toyonensis spores with alum improves bovine herpesvirus 5 subunit vaccine immune response in mice
|
Maubrigades, Lucas Reichert |
|
|
38 |
51 |
p. 8216-8223 |
artikel |
6 |
Carriage of Haemophilus influenzae among children attending childcare centres in Kuala Lumpur, Malaysia in the post vaccination era: A cross-sectional study
|
Palaniappan, Prem Ananth |
|
|
38 |
51 |
p. 8232-8237 |
artikel |
7 |
Cooling to reduce the pain associated with vaccination: A systematic review
|
Hall, Leanne M. |
|
|
38 |
51 |
p. 8082-8089 |
artikel |
8 |
COVID-19: The worst date to the senior dance
|
Bothun, Luke S. |
|
|
38 |
51 |
p. 8066-8067 |
artikel |
9 |
Development of a high-dose vaccine formulation for prevention of megalocytivirus infection in rock bream (Oplegnathus fasciatus)
|
Kwon, Woo Ju |
|
|
38 |
51 |
p. 8107-8115 |
artikel |
10 |
Durability of humoral immune responses to rubella following MMR vaccination
|
Crooke, Stephen N. |
|
|
38 |
51 |
p. 8185-8193 |
artikel |
11 |
Editorial Board/Aims and Scope
|
|
|
|
38 |
51 |
p. IFC |
artikel |
12 |
Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen®) vaccine for immunization of adolescents and adults in Thailand
|
Fortuna, Librada |
|
|
38 |
51 |
p. 8194-8199 |
artikel |
13 |
Epidemiological distribution of hepatitis B virus genotypes in 1–29-year-olds in the mainland of China
|
Su, Qiu-dong |
|
|
38 |
51 |
p. 8238-8246 |
artikel |
14 |
Epidemiology of rotavirus diarrhea among children less than 5 years hospitalized with acute gastroenteritis prior to rotavirus vaccine introduction in India
|
Girish Kumar, C.P. |
|
|
38 |
51 |
p. 8154-8160 |
artikel |
15 |
Estimated influenza illnesses and hospitalizations averted by influenza vaccination among children aged 6–59 months in Suzhou, China, 2011/12 to 2015/16 influenza seasons
|
Zhang, Wanqing |
|
|
38 |
51 |
p. 8200-8205 |
artikel |
16 |
Fractionation of tick saliva reveals proteins associated with the development of acquired resistance to Ixodes scapularis
|
Černý, Jiří |
|
|
38 |
51 |
p. 8121-8129 |
artikel |
17 |
Geographic hot spot analysis of vaccine exemption clustering patterns in Michigan from 2008 to 2017
|
Mashinini, Duduzile P. |
|
|
38 |
51 |
p. 8116-8120 |
artikel |
18 |
HPV cervical infections and serological status in vaccinated and unvaccinated women
|
Murall, Carmen Lía |
|
|
38 |
51 |
p. 8167-8174 |
artikel |
19 |
Influenza vaccination effectiveness in preventing influenza hospitalization in children, Hong Kong, winter 2019/20
|
Chiu, Susan S. |
|
|
38 |
51 |
p. 8078-8081 |
artikel |
20 |
NanH and PknG putative virulence factors as a recombinant subunit immunogen against Corynebacterium pseudotuberculosis infection in mice
|
Thais de Oliveira Silva, Mara |
|
|
38 |
51 |
p. 8099-8106 |
artikel |
21 |
Protection against leptospirosis conferred by Mycobacterium bovis BCG expressing antigens from Leptospira interrogans
|
Dorneles, Jessica |
|
|
38 |
51 |
p. 8136-8144 |
artikel |
22 |
Repeated exposure to an MF-59 adjuvanted quadrivalent subunit influenza vaccine (aQIV) in children: Results of two revaccination studies
|
Vesikari, Timo |
|
|
38 |
51 |
p. 8224-8231 |
artikel |
23 |
Safety biomarkers for development of vaccines and biologics: Report from the safety biomarkers symposium held on November 28–29, 2017, Marcy l’Etoile, France
|
Doubovetzky, Michel |
|
|
38 |
51 |
p. 8055-8063 |
artikel |
24 |
The demand for a COVID-19 vaccine in Ecuador
|
Sarasty, Oscar |
|
|
38 |
51 |
p. 8090-8098 |
artikel |
25 |
The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in development
|
Vyse, Andrew |
|
|
38 |
51 |
p. 8068-8070 |
artikel |
26 |
Vaccine as a Platform (VaaP): Why the future of disease eradication needs to be data driven
|
Justhy, Deva Prasad |
|
|
38 |
51 |
p. 8071-8074 |
artikel |
27 |
Vaccine mandates in the US and Australia: balancing benefits and burdens for children and physicians
|
Navin, Mark C. |
|
|
38 |
51 |
p. 8075-8077 |
artikel |
28 |
Vaccine storage and distribution between expanded program on immunization and medical store department in Tanzania: a cost-minimization analysis
|
Bulula, Ngwegwe |
|
|
38 |
51 |
p. 8130-8135 |
artikel |
29 |
‘Welcome to the bargepole clinic’
|
Williams, Andrew N. |
|
|
38 |
51 |
p. 8064-8065 |
artikel |